Myeloma Treatment News: What’s Changing?

Myeloma Treatment News: What’s Changing?

What's the latest news for myeloma treatments? New myeloma treatments were discussed at the American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) conferences. Will this new information change the standard of care for myeloma patients?

In this segment from our recent Myeloma Answers Now program, host Andrew Schorr has a conversation with Dr. Luciano Costa from the University of Alabama at Birmingham O’Neal Comprehensive Cancer Center and Dr. Joshua Richter of Tisch Cancer Institute at Mount Sinai. Watch as they discuss results from the ENDURANCE trial, other myeloma clinical trials involving daratumumab and how new treatments are being approved during COVID-19.

This is the first of a four-part series. Click on the part to view the other parts in the series: Part 2, Part 3, Part 4.

This program is sponsored by Janssen Biotech, Inc. This organization has no editorial control. It is produced by Patient Power and Patient Power is solely responsible for the content.

This article was originally published July 15, 2020 and most recently updated January 14, 2022.
© 2024 HealthCentral LLC. All rights reserved.

More on Multiple Myeloma